Skip to main content
v2026.11,986 entries · CC-BY 4.0

Epilepsy Research: Definitions, Funders, and Evidence

Epilepsy research explained: ILAE definition, WHO burden figures, funders, rural China treatment-gap studies and why no single seizure trigger ranks first.

Written and maintained by CASRAI Editorial Board

Published

On this page

Epilepsy research is the scientific study of epilepsy, a brain disorder defined by an enduring predisposition to generate seizures. It runs from basic neuroscience and genetics through clinical studies and trials to public-health work on treatment access. The World Health Organization (WHO) estimates that about 50 million people live with epilepsy worldwide, and its 2022-2031 global action plan lists research and innovation as one of five strategic objectives. No single trigger is the “number one” cause of seizures: studies of triggers rank stress, sleep deprivation and missed medication differently depending on how the data were collected.

Definition and scope: what counts as epilepsy research

Research needs a shared definition of its subject. The International League Against Epilepsy (ILAE) published a practical clinical definition in 2014 (Fisher et al., Epilepsia 55(4):475-482). Its conceptual definition, from 2005, is an enduring predisposition to generate epileptic seizures. The practical definition says a person has epilepsy when any one of three conditions is met:

ILAE 2014 criterion What must be true
1 At least two unprovoked (or reflex) seizures more than 24 hours apart
2 One unprovoked (or reflex) seizure and a probability of further seizures similar to the general recurrence risk (at least 60%) over the next 10 years
3 Diagnosis of an epilepsy syndrome

The same paper describes epilepsy as “resolved” when a person has passed the age of an age-dependent syndrome, or has been seizure-free for 10 years with no antiseizure medicine for at least the last 5 years. Resolved is not identical to cured, which matters when a study reports “remission” or “outcome”. A study that uses a different case definition than another study is measuring a different population, so definitions come before any comparison of results. Researchers who need a refresher on the specialty itself can start with what neurology is and what neuroscience is.

How epilepsy research is organised in practice

Epilepsy research has several layers that are funded and reported differently. The layers below are drawn from the WHO and from one non-profit funder that publishes its own programme figures.

Global priorities: the WHO action plan

The 75th World Health Assembly endorsed the Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders 2022-2031 in May 2022 (resolution WHA75(11)). The plan has five strategic objectives, one of which is to foster research and innovation and strengthen information systems, and it sets ten global targets with indicators to be met by 2031. WHO’s announcement also notes that neurological disorders account for about 9 million deaths a year. For a research office, the practical point is that “information systems” sits in the same objective as research: counting people with epilepsy and tracking treatment is treated as part of the research agenda, not a separate administrative task.

Disease burden that frames the questions

The WHO epilepsy fact sheet gives the figures that most epilepsy papers cite in their introductions: about 50 million people with epilepsy, about 5 million people diagnosed each year, and a prevalence of active epilepsy of 4 to 10 per 1,000 people. Roughly 80% of people with epilepsy live in low- and middle-income countries, and the cause is unknown in about half of cases. When a cause is identified, WHO groups it as structural, genetic, infectious, metabolic, immune or unknown. WHO also reports that about three quarters of people with epilepsy in low-income countries do not get the treatment they need, and that generic antiseizure medicines are available in fewer than half of public-sector facilities in low- and middle-income countries.

Funders and targeted programmes

Funders shape which questions get studied. CURE Epilepsy, a non-profit funder, reports on its own website that it has raised $100 million and funded about 300 grants in 19 countries. It lists seed grants for high-risk, high-reward science, team-science awards, a sudden unexpected death in epilepsy (SUDEP) research programme, an Infantile Spasms Initiative and a post-traumatic epilepsy partnership with the US Department of Defense. These are the funder’s own figures and priorities, so treat them as a description of what that funder supports, not as a measure of the whole field. For how grant mechanisms of this kind are structured in the United States, see the dictionary entry on the NIH R01 research project grant.

Measurement tools in the lab and clinic

Electrophysiology remains a core measurement in epilepsy studies. For readers building protocols, the guides on EEG channels and magnetoencephalography explain what the recording systems capture. Registering trials is a separate obligation; see clinical trial transparency.

What is the newest research on epilepsy?

Which paper is newest changes weekly, so the useful answer is where the field’s current priorities are written down. Three current frames are documented above: the ILAE definition that defines who counts as a case, the WHO 2022-2031 action plan that sets global research and information-system objectives, and funder programmes such as SUDEP research, infantile spasms and post-traumatic epilepsy. For individual new studies, a PubMed search on “epilepsy” sorted by date lists them, and a funder’s grant list shows what is being supported before results are published.

Is there a number one trigger for epilepsy?

No study sources a single universal number one. The ranking depends on the method, as two published studies show.

A cross-sectional online questionnaire of 546 people with epilepsy in Saudi Arabia (Alshamrani et al., Saudi Medical Journal 2020;41(8):828-833) found sleep deprivation was the most reported trigger (52%), followed by stress (41%), missed medication (38.5%), anxiety (38.3%) and fatigue (33.7%). The authors note that a self-administered survey is a limitation compared with seizure diaries and long-term monitoring.

A US smartwatch study (Ge et al., Epilepsy and Behavior 2022;126:108472) asked participants to complete a survey straight after each tracked seizure. 234 participants tracked 2,493 seizures, and 96 participants reported triggers for 650 seizures. Stress (65.8%) was the most common, followed by lack of sleep (30.5%), menstrual cycle (19.7%) and overexertion (18%). Participants often reported several triggers together.

The two studies differ in country, method (retrospective survey about past seizures versus a report after each seizure), population and what was counted, so their percentages are not directly comparable. Both are self-reported, which describes what people believe preceded seizures and does not prove cause. This page gives no advice on managing seizures; people with epilepsy should talk to their own clinician.

How do the Chinese treat epilepsy?

The research record in China is mostly about closing the gap between people who have epilepsy and people who receive regular treatment. Standard care in studies is drug treatment delivered through the health system, consistent with WHO’s description of antiseizure medicines as the usual first-line approach, and the studies below do not evaluate traditional medicine, so nothing here supports or rejects it.

The Global Campaign Against Epilepsy demonstration project in rural China (Wang et al., Bulletin of the World Health Organization 2008;86(12):964-969) ran in five provinces. After a community intervention combining a treatment programme and public health education, the second survey of 51,644 people found a lifetime epilepsy prevalence of 6.2 per 1,000 and an active-epilepsy prevalence of 4.5 per 1,000. The treatment gap for active epilepsy fell from 62.6% to 49.8%. A separate rural Guangxi study (Huang et al., Genetics and Molecular Research 2014;13(3):6202-6212) of 302 patients reported a treatment gap of 79.1%, showing how much the gap varied between settings.

What do people with epilepsy experience?

Research on lived experience is one of the questions the field studies, and it is why triggers, auras and other seizure features are recorded in the first place. The smartwatch study above collected, after each seizure, the seizure type, any warning symptoms (auras), loss of awareness and rescue-medication use, in addition to triggers. Experience varies widely between people and between seizure types, so general descriptions are limited. A person seeking information about their own condition should use the resources of a national epilepsy organisation and their treating clinician.

Searches for “epilepsy research” return several different things that share a name. The data table below lists the figures from the sources above; the list here separates the entities.

  • The research field. The subject of this page: the study of epilepsy across basic, clinical and public-health work.
  • Journals with similar titles. At least two journals carry close titles: Epilepsy Research (published by Elsevier on ScienceDirect) and the Journal of Epilepsy Research (j-epilepsy.org). Journal-level details such as impact factor, indexing and author instructions come from each journal’s own pages and from the indexers’ own lists, so check them there with the date you read them.
  • Charities and institutes. Organisations such as CURE Epilepsy and the Epilepsy Research Institute in the UK fund or direct research. Each reports its own figures.

Where it matters for labs, clinics and research offices

  • Case definition. Confirm which definition a study used (the ILAE 2014 criteria or another) before pooling or comparing results.
  • Self-report versus recorded data. Trigger studies built on recall surveys and on post-seizure reports give different rankings, as shown above.
  • Treatment-gap framing. Studies in lower-resource settings report treatment gaps, which changes what outcomes are feasible to measure.
  • Funder-reported figures. Totals reported by a funder describe its own portfolio; cite them as the funder’s figures.

Common misunderstandings

  • “One seizure means epilepsy.” Under the ILAE practical definition, one seizure counts only if the probability of recurrence is at least 60% over 10 years, or an epilepsy syndrome is diagnosed.
  • “Resolved means cured.” The ILAE paper states these are not identical.
  • “Epilepsy research is only about drugs.” The WHO plan includes information systems, and funders list areas such as SUDEP and post-traumatic epilepsy.
  • “A trigger percentage is a cause.” The percentages above are self-reported associations.

Frequently asked questions

What is the newest research on epilepsy?

The documented current frames are the WHO 2022-2031 action plan, which has a research and innovation objective, and funder priorities such as SUDEP, infantile spasms and post-traumatic epilepsy. Individual new papers are found by a date-sorted PubMed search.

What do people with epilepsy experience?

It varies by person and seizure type. Research records seizure type, warning symptoms, loss of awareness and triggers; for personal questions, a treating clinician is the right source.

How do the Chinese treat epilepsy?

Published studies from China describe community and health-system treatment programmes aimed at the treatment gap, which fell from 62.6% to 49.8% in the rural Global Campaign Against Epilepsy project. They do not evaluate traditional medicine.

What is the number one trigger for epilepsy?

There is no single one. A Saudi survey ranked sleep deprivation first (52%); a US smartwatch study ranked stress first (65.8% of seizures with a reported trigger).

How is epilepsy defined for research?

By the ILAE 2014 practical definition: two unprovoked seizures more than 24 hours apart, or one seizure with at least a 60% recurrence probability over 10 years, or an epilepsy syndrome diagnosis.

How many people have epilepsy?

WHO estimates about 50 million people worldwide, with about 5 million diagnosed each year.

Sources

  • World Health Organization, Epilepsy fact sheet: who.int/news-room/fact-sheets/detail/epilepsy (read 2026-11-19).
  • World Health Organization, New global action plan on epilepsy and other neurological disorders published, 20 July 2023: who.int news item (read 2026-11-19).
  • Fisher RS et al., ILAE official report: a practical clinical definition of epilepsy, Epilepsia 2014;55(4):475-482: PubMed 24730690 (read 2026-11-19).
  • CURE Epilepsy, programme and funding overview: cureepilepsy.org (read 2026-11-19).
  • Alshamrani FJ et al., Epilepsy trigger factors in Saudi Arabia, Saudi Med J 2020;41(8):828-833: PMC7502962 (read 2026-11-19).
  • Ge A et al., Seizure triggers identified postictally using a smart watch reporting system, Epilepsy Behav 2022;126:108472: PubMed 34942507 (read 2026-11-19).
  • Wang W et al., Global campaign against epilepsy: assessment of a demonstration project in rural China, Bull World Health Organ 2008;86(12):964-969: PubMed 19142297 (read 2026-11-19).
  • Huang DH et al., Treatment gaps of epilepsy and retention rates of sodium valproate in rural Guangxi, China, Genet Mol Res 2014;13(3):6202-6212: PubMed 25158247 (read 2026-11-19).

Data: Epilepsy research reference figures by source and setting

Figures quoted in epilepsy research introductions and trigger studies, compiled from the WHO fact sheet, the ILAE definition paper and three peer-reviewed studies, with the setting and method of each figure.

Period covered: 2008/2022.

Epilepsy research reference figures by source and setting
MeasureValueUnitSetting and methodSource
People with epilepsy worldwide50million peopleGlobal estimateWHO epilepsy fact sheet
People diagnosed with epilepsy each year5million peopleGlobal estimateWHO epilepsy fact sheet
Share of people with epilepsy in low- and middle-income countries80percentGlobal estimateWHO epilepsy fact sheet
Active epilepsy prevalence, rural China, after intervention4.5per 1,000Door-to-door survey of 51,644 people, five provincesWang et al. 2008
Treatment gap, active epilepsy, rural China, before intervention62.6percentCommunity survey, five provincesWang et al. 2008
Treatment gap, active epilepsy, rural China, after intervention49.8percentCommunity survey, five provincesWang et al. 2008
Treatment gap, rural Guangxi79.1percent302 enrolled patientsHuang et al. 2014
Most reported trigger: sleep deprivation52percent of respondentsOnline questionnaire, 546 patients, Saudi ArabiaAlshamrani et al. 2020
Most common reported trigger: stress65.8percent of seizures with a reported triggerPost-seizure smartwatch survey, 650 seizuresGe et al. 2022
Lack of sleep as reported trigger30.5percent of seizures with a reported triggerPost-seizure smartwatch survey, 650 seizuresGe et al. 2022

Sources

Compiled by CASRAI from the sources above. Free to reuse under CC BY 4.0 with attribution.

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · full access

Ask about Epilepsy Research: Definitions, Funders, and Evidence

Full access: large monthly usage, up to 10 source passages behind each answer, and MCP and API access for Claude Code, Codex and other CLIs. Cancel any time.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →